cochlear nucleus 8 sound processor

Cochlear Announces FDA Approval of Nucleus 8 CI Sound Processor

LONE TREE, COLORADO — Cochlear Limited (ASX: COH), a global leader in implantable hearing solutions, has announced U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. According to the company, the Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry.1-3 It is also…

Read More
hearing test predicts language infants

Researchers Find Cortical Auditory Evoked Potentials in 1 Month Old Infants Can Predict Language Outcomes at 12 Months

Portuguese researchers have proven that hearing assessment in early-age infants can help predict milestones and early detection of neurodevelopmental disorder markers. Several studies suggest that the brain’s response to different auditory stimulus intensities in newborn babies can provide important information about basic auditory sensory processing skills, with cascading effects on aspects such as behavioral organization,…

Read More
tuned musicares

Tuned and MusiCares® Team Up to Provide Hearing Care Assistance to the Music Industry

NEW YORK and SANTA MONICA — Tuned, an online hearing health company, and MusiCares®, the leading music charity supporting the health and welfare of the music community through preventive, emergency, and recovery programs, today announced a partnership that will bring comprehensive hearing care to MusiCares’ clients across the U.S.   Tuned and MusiCares Partnership   Music industry professionals are a…

Read More

Advanced Bionics Launches Emotional Patient ‘THE MOMENT’ Campaign

VALENCIA, CALIFORNIA — Cochlear implant maker, Advanced Bionics, announced the launch of an emotional patient ‘connection’ campaign. Following the successful launch of their Naída CI Marvel for adults and Sky CI Marvel for children in 2020, this new campaign is designed to “highlight the human truth that our lives are enriched and fulfilled by deep…

Read More
hearing technology innovator winners 2022

2022 Hearing Technology Innovator Awards – Winners Announced!

Hearing Health & Technology Matters today announces the winners of its third annual Hearing Technology Innovator Awards™. Through the annual awards program, HHTM honors technological innovation and achievement in the hearing industry. This year’s expanded program was the most competitive yet and received entries from some of the most innovative companies from around the world.…

Read More
lilly acquires akouos

Eli Lilly to Acquire Akouos and its Hearing Loss Gene Therapy Portfolio, for $487M

INDIANAPOLIS and BOSTON — Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a precision genetic medicine company that is developing a portfolio of first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss. “We are honored to work with the talented team…

Read More
hearing loss gene therapy db-oto

Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO Hearing Loss Gene Therapy Product Candidate

BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 1/2 clinical trial in pediatric…

Read More
cochlear implant textbook

Complex Cochlear Implant Cases: Management and Troubleshooting

SAN DIEGO, CALIFORNIA — Not all cochlear implant cases present in a traditional manner, which calls for audiologists to seek a second opinion in more intricate and difficult cases. Complex Cochlear Implant Cases: Management and Troubleshooting offers both new and experienced cochlear implant audiologists the opportunity to tap into the knowledge and experience of skilled…

Read More
otonomy hearing loss drug

Otonomy Clinical Results for OTO-413 Disappoint; No Meaningful Improvement Observed in Hearing Loss Patients

SAN DIEGO, CALIFORNIA — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that the clinical evaluation of higher doses for OTO-413 (0.75 mg and 1.50 mg) in patients with hearing loss demonstrated no clinically meaningful improvement for patients from baseline across multiple speech-in-noise (SIN) hearing…

Read More
otc hearing aids fda

FDA Offers Clarification to States Regarding Final OTC Hearing Aid Rule

WASHINGTON, D.C. — Today, the U.S. Food and Drug Administration (FDA) sent a letter to state officials offering clarifications about the Final Rule on OTC Hearing Aids, following requests by several professional organizations seeking to better understand the distinction between ‘Prescription’ and ‘OTC’ hearing aid categories. In part, the letter states, “We have received questions about…

Read More